Unknown

Dataset Information

0

Bendamustine with total body irradiation conditioning yields tolerant T-cells while preserving T-cell-dependent graft-versus-leukemia.


ABSTRACT: Graft-versus-host disease (GvHD) remains a significant impediment to allogeneic hematopoietic cell transplantation (HCT) success, necessitating studies focused on alleviating GvHD, while preserving the graft-versus-leukemia (GvL) effect. Based on our previous studies showing bendamustine with total body irradiation (BEN-TBI) conditioning reduces GvHD compared to the current clinical standard of care cyclophosphamide (CY)-TBI in a murine MHC-mismatched bone marrow transplantation (BMT) model, this study aimed to evaluate the role and fate of donor T-cells following BEN-TBI conditioning. We demonstrate that BEN-TBI reduces GvHD compared to CY-TBI independently of T regulatory cells (Tregs). BEN-TBI conditioned mice have a smaller proportion and less activated donor T-cells, with lower CD47 expression, early post-transplant, but no sustained phenotypic differences in T-cells. In BEN-TBI conditioned mice, donor T-cells gain tolerance specific to host MHC antigens. Though these T-cells are tolerant to host antigens, we demonstrate that BEN-TBI preserves a T-cell-dependent GvL effect. These findings indicate that BEN-TBI conditioning reduces GvHD without compromising GvL, warranting its further investigation as a potentially safer and more efficacious clinical alternative to CY-TBI.

PROVIDER: S-EPMC7199810 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC7571287 | BioStudies
| S-EPMC7378358 | BioStudies
| S-EPMC4917459 | BioStudies
| S-EPMC8264365 | BioStudies
| S-EPMC2630281 | BioStudies
| S-EPMC7556327 | BioStudies
| S-EPMC5726600 | BioStudies
| S-EPMC7726260 | BioStudies
| S-EPMC6849938 | BioStudies
| S-EPMC8663779 | BioStudies